Shared Inflammatory Gene Programs between Immune Thrombocytopenia and CKD-Related Autoimmune Nephropathies: An Exploratory Transcriptomic and Bioinformatic Study
By: Xin He, Meiling Jin and Qianmei Sun
References
- 1.
Liu XG, Hou Y, Hou M. How we treat primary immune thrombocytopenia in adults. J Hematol Oncol. 2023;16(1):4.
10.1186/s13045-023-01401-z
.
LiuXG HouY HouM How we treat primary immune thrombocytopenia in adults J Hematol Oncol 2023 16 1 4 10.1186/s13045-023-01401-z
- Nokhostin F, Bakhshpour F, Pezeshki SMS, Khademi R, Saki N. Immune thrombocytopenia: a review on the pathogenetic role of immune cells. Expert Rev Hematol. 2023;16(10):731–742. 10.1080/17474086.2023.2255750.
- Nishizawa K, Yamashita T, Ogawa Y, Kobayashi H. Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review. CEN Case Rep. 2022;11(1):43–49. 10.1007/s13730-021-00630-w.
- Alkindi S, Khan S, Riyami D, Farooqi M, Pathare A. Coexistence of immune thrombocytopenic purpura and idiopathic membranous glomerulonephritis successfully treated with rituximab. Platelets. 2010;21(7):575–577. 10.3109/09537104.2010.494744.
- Kahraman C, Emre H, Gulcan E, Bilen Y, Uludag K, Uyanik A, Keleş M. Combined immune thrombocytopenic purpura and immunoglobulin A nephropathy: a similar pathophysiologic process? Ren Fail. 2014;36(3):464–465. 10.3109/0886022x.2013.872568.
- August P. Chronic Kidney Disease - Another Step Forward. N Engl J Med. 2023;388(2):179–180. 10.1056/NEJMe2215286.
- Fu Z, Geng X, Liu C, Shen W, Dong Z, Sun G, Cai G, Chen X, Hong Q. Identification of common and specific fibrosis-related genes in three common chronic kidney diseases. Ren Fail. 2024;46(1):2295431. 10.1080/0886022x.2023.2295431.
- Wu Y, Jiang H, Hu Y, Dai H, Zhao Q, Zheng Y, Liu W, Rui H, Liu B. B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges. Int Immunopharmacol. 2024;140(112769. 10.1016/j.intimp.2024.112769.
- Cheung CK, Alexander S, Reich HN, Selvaskandan H, Zhang H, Barratt J. The pathogenesis of IgA nephropathy and implications for treatment. Nat Rev Nephrol. 2025;21(1):9–23. 10.1038/s41581-024-00885-3.
- So BYF, Yap DYH, Chan TM. B Cells in Primary Membranous Nephropathy: Escape from Immune Tolerance and Implications for Patient Management. Int J Mol Sci. 2021;22(24):10.3390/ijms222413560.
- Suzuki Y. B cell targeting in IgA nephropathy. Nephrology (Carlton). 2024;29 Suppl 2(39–43. 10.1111/nep.14367.
- Chen X, Guo H, Jin D, Lu Y, Zhang L. Distribution characteristics of circulating B cell subpopulations in patients with chronic kidney disease. Sci Rep. 2023;13(1):20797. 10.1038/s41598-023-47742-0.
- Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. 10.1186/s13059-014-0550-8.
- Han P, Hou Y, Zhao Y, Liu Y, Yu T, Sun Y, Wang H, Xu P, Li G, Sun T, Hu X, Liu X, Li L, Peng J, Zhou H, Hou M. Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia. Blood. 2021;138(8):674–688. 10.1182/blood.2020008477.
- Zhang H, Zhang BM, Guo X, Xu L, You X, West RB, Bussel JB, Zehnder JL. Blood transcriptome and clonal T-cell correlates of response and non-response to eltrombopag therapy in a cohort of patients with chronic immune thrombocytopenia. Haematologica. 2020;105(3):e129–e132. 10.3324/haematol.2019.226688.
- Jernås M, Strömberg Célind F, Nookaew I, Mellgren K, Wadenvik H, Olsson B. Normalised immune expression in remission of paediatric ITP. Thromb Haemost. 2016;115(6):1229–1230. 10.1160/th15-12-0976.
- Jernås M, Hou Y, Strömberg Célind F, Shao L, Nookaew I, Wang Q, Ju X, Mellgren K, Wadenvik H, Hou M, Olsson B. Differences in gene expression and cytokine levels between newly diagnosed and chronic pediatric ITP. Blood. 2013;122(10):1789–1792. 10.1182/blood-2013-05-502807.
- Jernås M, Nookaew I, Wadenvik H, Olsson B. MicroRNA regulate immunological pathways in T-cells in immune thrombocytopenia (ITP). Blood. 2013;121(11):2095–2098. 10.1182/blood-2012-12-471250.
- Olsson B, Andersson PO, Jernås M, Jacobsson S, Carlsson B, Carlsson LM, Wadenvik H. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9(9):1123–1124. 10.1038/nm921.
- Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. 10.1093/nar/gkv007.
- Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, Mc-Crae KR, Pruitt B, Shimanek H, Vesely SK. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829–3866. 10.1182/bloodadvances.2019000966.
- Lee KH, Kronbichler A, Park DD, Park Y, Moon H, Kim H, Choi JH, Choi Y, Shim S, Lyu IS, Yun BH, Han Y, Lee D, Lee SY, Yoo BH, Lee KH, Kim TL, Kim H, Shim JS, Nam W, So H, Choi S, Lee S, Shin JI. Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review. Autoimmun Rev. 2017;16(11):1160–1173. 10.1016/j.autrev.2017.09.012.
- Nakazawa D, Masuda S, Nishibata Y, Watanabe-Kusunoki K, Tomaru U, Ishizu A. Neutrophils and NETs in kidney disease. Nat Rev Nephrol. 2025;21(6):383–398. 10.1038/s41581-025-00944-3.
- Waters LR, Ahsan FM, Wolf DM, Shirihai O, Teitell MA. Initial B Cell Activation Induces Metabolic Reprogramming and Mitochondrial Remodeling. iScience. 2018;5(99–109. 10.1016/j.isci.2018.07.005.
- Zheng Y, Wang S, Wu J, Wang Y. Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy. J Transl Med. 2023;21(1):510. 10.1186/s12967-023-04367-1.
- Verma S, Singh P, Khurana S, Ganguly NK, Kukreti R, Saso L, Rana DS, Taneja V, Bhargava V. Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies. Kidney Res Clin Pract. 2021;40(2):183–193. 10.23876/j.krcp.20.163.
- Abrink M, Grujic M, Pejler G. Serglycin is essential for maturation of mast cell secretory granule. J Biol Chem. 2004;279(39):40897–40905. 10.1074/jbc.M405856200.
- Grujic M, Braga T, Lukinius A, Eloranta ML, Knight SD, Pejler G, Abrink M. Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage. J Biol Chem. 2005;280(39):33411–33418. 10.1074/jbc.M501708200.
- Zernichow L, Abrink M, Hallgren J, Grujic M, Pejler G, Kolset SO. Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-alpha secretion in response to lipopolysaccharide. J Biol Chem. 2006;281(37):26792–26801. 10.1074/jbc.M512889200.
- Theocharis AD, Seidel C, Borset M, Dobra K, Baykov V, Labropoulou V, Kanakis I, Dalas E, Karamanos NK, Sundan A, Hjerpe A. Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro. J Biol Chem. 2006;281(46):35116–35128. 10.1074/jbc.M601061200.
- Crickx E, Mahévas M. B-cell responses to ITP treatments. Br J Haematol. 2024;204(2):397–398. 10.1111/bjh.19199.
- Xu C, Zhang R, Duan M, Zhou Y, Bao J, Lu H, Wang J, Hu M, Hu Z, Zhou F, Zhu W. A polygenic stacking classifier revealed the complicated platelet transcriptomic landscape of adult immune thrombocytopenia. Mol Ther Nucleic Acids. 2022;28(477–487. 10.1016/j.omtn.2022.04.004.
- Zhao Y, Xu P, Guo L, Wang H, Min Y, Feng Q, Hou Y, Sun T, Li G, Ji X, Qiu J, Peng J, Liu X, Hou M. Tumor Necrosis Factor-α Blockade Corrects Monocyte/Macrophage Imbalance in Primary Immune Thrombocytopenia. Thromb Haemost. 2021;121(6):767–781. 10.1055/s-0040-1722186.
- Prestele M, Vogel F, Reichert AS, Herrmann JM, Ott M. Mrpl36 is important for generation of assembly competent proteins during mitochondrial translation. Mol Biol Cell. 2009;20(10):2615–2625. 10.1091/mbc.e08-12-1162.
- Wang C, Gao Y, Luan C, Sun W, Ge S, Li Y, Xu L, Du Q, Liu W, Lu G, Gong W, Ma X. Zinc finger protein ZBTB17 controls cellular senescence via interacting with nuclear receptor RXRA and its downstream calcium signaling. Faseb j. 2023;37(10):e23193. 10.1096/fj.202301050R.
- He Y, Hara H, Núñez G. Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem Sci. 2016;41(12):1012–1021. 10.1016/j.tibs.2016.09.002.
- Wang S, Liu Y, Li G, Feng Q, Hou M, Peng J. Reduced intracellular antioxidant capacity in platelets contributes to primary immune thrombocytopenia via ROS-NLRP3-caspase-1 pathway. Thromb Res. 2021;199(1–9. 10.1016/j.thromres.2020.12.008.
- Anders HJ, Fernandez-Juarez GM, Vaglio A, Romagnani P, Floege J. CKD therapy to improve outcomes of immune-mediated glomerular diseases. Nephrol Dial Transplant. 2023;38(Suppl 2):ii50–ii57. 10.1093/ndt/gfad069.
- Boesen EI, Kakalij RM. Autoimmune-mediated renal disease and hypertension. Clin Sci (Lond). 2021;135(17):2165–2196. 10.1042/cs20200955.
DOI: https://doi.org/10.2478/bjmg-2025-00027 | Journal eISSN: 2199-5761
Language: English
Page range: 73 - 84
Published on: May 14, 2026
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2026 Xin He, Meiling Jin, Qianmei Sun, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.